Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06651151
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-18
Brief Title:
NeoLIPA Neoadjuvant LTX-315 in Combination with Pembrolizumab in Resectable Stage IIIIV Melanoma
Sponsor:
Organization:
None